Victek Co., Ltd. (KOSDAQ:065450)
4,300.00
-180.00 (-4.02%)
At close: May 20, 2026
Victek Revenue
In the year 2025, Victek had annual revenue of 82.96B KRW with 16.04% growth. Victek had revenue of 28.84B in the quarter ending December 31, 2025, with 9.51% growth.
Revenue
82.96B
Revenue Growth
+16.04%
P/S Ratio
1.49
Revenue / Employee
359.12M
Employees
231
Market Cap
123.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 82.96B | 11.47B | 16.04% |
| Dec 31, 2024 | 71.49B | 16.56B | 30.15% |
| Dec 31, 2023 | 54.93B | 24.06B | 77.95% |
| Dec 31, 2011 | 30.87B | -11.81B | -27.68% |
| Dec 31, 2010 | 42.68B | -8.89B | -17.24% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Haesung Optics | 160.33B |
| Mercury | 123.87B |
| ESTsoft | 106.79B |
| WINS Technet | 98.60B |
| OPTUS Pharmaceutical | 87.16B |
| Model Solution | 76.50B |
| Fidelix | 69.08B |
| Genians | 48.38B |